Literature DB >> 33796395

Blood viscosity of COVID-19 patient: a preliminary report.

Beuy Joob1, Viroj Wiwanitkit2.   

Abstract

COVID-19 is the important global problem. This new coronavirus can cause several hematological changes. Thrombosis is a problem might occur in COVID-19. In COVID-19, thrombosis might be the result of endothelial dysfunction, platelet activation, increasd blood viscosity, and blood flow disturbance. The change of blood viscosity in the patients with COVID-19 is possible but little mentioned. Here, the authors report on a preliminary data on blood viscosity assessment among 41 COVID-19 patients. According to the estimation, the estimated blood viscosity values are 72.4 ± 18.6 and 18.2 ± 2.2 for high and low shear rates. Based on this preliminary report, the increased blood viscosity is detected in COVID-19 patient and it might be associated with thrombohemostatic problem. AJBR
Copyright © 2021.

Entities:  

Keywords:  COVID-19; blood; viscosity

Year:  2021        PMID: 33796395      PMCID: PMC8010604     

Source DB:  PubMed          Journal:  Am J Blood Res        ISSN: 2160-1992


  18 in total

Review 1.  Changes in the Blood Viscosity in Patients With SARS-CoV-2 Infection.

Authors:  Hayder M Al-Kuraishy; Ali I Al-Gareeb; Sadiq M Al-Hamash; Simona Cavalu; Maisra M El-Bouseary; Fatma I Sonbol; Gaber El-Saber Batiha
Journal:  Front Med (Lausanne)       Date:  2022-06-17

2.  Time-related aortic inflammatory response in severely or critical COVID-19.

Authors:  Rujittika Mungmunpuntipantip; Viroj Wiwanitkit
Journal:  J Nucl Cardiol       Date:  2022-05-24       Impact factor: 3.872

3.  COVID-19 and Light Chain Amyloidosis: Correspondence.

Authors:  Rujittika Mungmunpuntipantip; Viroj Wiwanitkit
Journal:  Am J Med       Date:  2022-06       Impact factor: 5.928

4.  A 2D FSI mathematical model of blood flow to analyze the hyper-viscous effects in atherosclerotic COVID patients.

Authors:  Shankar Narayan S; Sunanda Saha; Anuradha Bhattacharjee
Journal:  Results Eng       Date:  2021-08-24

5.  Comment on glycated hemoglobin level after emergency COVID-19.

Authors:  Rujittika Mungmunpuntipantip; Viroj Wiwanitkit
Journal:  Geriatr Gerontol Int       Date:  2022-04-20       Impact factor: 3.387

Review 6.  COVID-19, neurovascular thrombotic problem and short summary on blood coagulation disorder: a brief review.

Authors:  Rujittika Mungmunpuntipantip; Viroj Wiwanitkit
Journal:  Egypt J Neurol Psychiatr Neurosurg       Date:  2022-01-10

7.  Non-invasive brain microcurrent stimulation therapy of long-COVID-19 reduces vascular dysregulation and improves visual and cognitive impairment.

Authors:  Bernhard A Sabel; Wanshu Zhou; Frank Huber; Florentina Schmidt; Kornelia Sabel; Andreas Gonschorek; Mirela Bilc
Journal:  Restor Neurol Neurosci       Date:  2021       Impact factor: 2.406

8.  Diabetic ketoacidosis, COVID-19 and blood viscosity.

Authors:  Rujittika Mungmunpuntipantip; Viroj Wiwanitkit
Journal:  J Taibah Univ Med Sci       Date:  2021-11-11

9.  Acute venous thromboembolism after COVID-19 vaccination.

Authors:  Rujittika Mungmunpuntipantip; Viroj Wiwanitkit
Journal:  J Vasc Surg Venous Lymphat Disord       Date:  2022-01

10.  Altered central and peripheral haemodynamics during rhythmic handgrip exercise in young adults with SARS-CoV-2.

Authors:  Nina L Stute; Abigail S L Stickford; Jonathon L Stickford; Valesha M Province; Marc A Augenreich; Kanokwan Bunsawat; Jeremy K Alpenglow; D Walter Wray; Stephen M Ratchford
Journal:  Exp Physiol       Date:  2021-08-17       Impact factor: 2.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.